Similar Tracks
PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 3
U.S. Food and Drug Administration
PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 1
U.S. Food and Drug Administration
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance
U.S. Food and Drug Administration
Clinicians Connect: Conversations w/ FDA's CMO on reducing cases of congenital syphilis & syphilis
U.S. Food and Drug Administration
Clinical Pharmacology Considerations for Novel Therapeutic Modalities
U.S. Food and Drug Administration
FDA Clinical Investigator Training Course (CITC) 2024 (Day 2 of 3)
U.S. Food and Drug Administration
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
U.S. Food and Drug Administration
PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 2
U.S. Food and Drug Administration
FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)
U.S. Food and Drug Administration
188th Meeting of the Vaccines and Related Biological Products Advisory Committee Meeting
U.S. Food and Drug Administration